Lactate-related biomarkers in severe acute pancreatitis: insights from machine learning, molecular dynamics, and experimental validation.
Source check: Source checked. Not independent scientific confirmation.
Finding: Specific biomarker/mechanistic result is linked to model-based prioritization and directly checked in patient samples/cell experiments; retain cohort association and in-vitro scope, and do not imply clinical utility. The bibliographic records retrieved do not state an author affiliation.
Technology: transcriptomic SAP vs non-SAP comparison; three ML methods nominate CCNA2 and H2BC5 among lactate-related genes; both higher in SAP clinical samples. Lactate addition and gene knockdown in vitro alter expression/inflammatory cytokines; Torin-1 reduced inflammation/oxidative stress in sodium-taurocholate cell model after docking/simulation. Evidence supports candidate biomarkers/mechanism in transcriptomic and cell models, not patient treatment efficacy.
Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.
- AI contribution
- transcriptomic SAP vs non-SAP comparison; three ML methods nominate CCNA2 and H2BC5 among lactate-related genes; both higher in SAP clinical samples. Lactate addition and gene knockdown in vitro alter expression/inflammatory cytokines; Torin-1 reduced inflammation/oxidative stress in sodium-taurocholate cell model after docking/simulation. Evidence supports candidate biomarkers/mechanism in transcriptomic and cell models, not patient treatment efficacy.
- Test and result
- transcriptomic SAP vs non-SAP comparison; three ML methods nominate CCNA2 and H2BC5 among lactate-related genes; both higher in SAP clinical samples. Lactate addition and gene knockdown in vitro alter expression/inflammatory cytokines; Torin-1 reduced inflammation/oxidative stress in sodium-taurocholate cell model after docking/simulation. Evidence supports candidate biomarkers/mechanism in transcriptomic and cell models, not patient treatment efficacy.
- Limitation / still unknown
- Specific biomarker/mechanistic result is linked to model-based prioritization and directly checked in patient samples/cell experiments; retain cohort association and in-vitro scope, and do not imply clinical utility. Methods/Results: transcriptomic SAP vs non-SAP comparison; three ML methods nominate CCNA2 and H2BC5 among lactate-related genes; both higher in SAP clinical samples. Lactate addition and gene knockdown in vitro alter expression/inflammatory cytokines; Torin-1 reduced inflammation/oxidative stress in sodium-taurocholate cell model after docking/simulation. Evidence supports candidate biomarkers/mechanism in transcriptomic and cell models, not patient treatment efficacy.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://link.springer.com/article/10.1186/s13036-025-00605-w
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 2/5 · Validation 3/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.